nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCD—saliva-secreting gland—thyroid cancer	0.0395	0.206	CbGeAlD
Ingenol Mebutate—PRKCD—trachea—thyroid cancer	0.0305	0.159	CbGeAlD
Ingenol Mebutate—PRKCA—neck—thyroid cancer	0.0279	0.146	CbGeAlD
Ingenol Mebutate—PRKCD—thyroid gland—thyroid cancer	0.0241	0.126	CbGeAlD
Ingenol Mebutate—PRKCD—Afatinib—Vandetanib—thyroid cancer	0.0236	1	CbGdCrCtD
Ingenol Mebutate—PRKCD—head—thyroid cancer	0.0214	0.112	CbGeAlD
Ingenol Mebutate—PRKCD—lymph node—thyroid cancer	0.015	0.0781	CbGeAlD
Ingenol Mebutate—PRKCA—thyroid gland—thyroid cancer	0.0133	0.0693	CbGeAlD
Ingenol Mebutate—PRKCA—head—thyroid cancer	0.0118	0.0615	CbGeAlD
Ingenol Mebutate—PRKCA—lymph node—thyroid cancer	0.00826	0.0431	CbGeAlD
Ingenol Mebutate—PRKCA—Cell Cycle—CDK1—thyroid cancer	0.000366	0.000467	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	0.000364	0.000464	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—AKT1—thyroid cancer	0.000363	0.000462	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—AKT1—thyroid cancer	0.000363	0.000462	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—TSHR—thyroid cancer	0.000362	0.000461	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—PTEN—thyroid cancer	0.000361	0.000461	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—PTEN—thyroid cancer	0.000361	0.000461	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CALCA—thyroid cancer	0.000361	0.00046	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—AKT1—thyroid cancer	0.000359	0.000458	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—HRAS—thyroid cancer	0.000358	0.000457	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—PTEN—thyroid cancer	0.000358	0.000457	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—BRAF—thyroid cancer	0.000357	0.000454	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—AKT1—thyroid cancer	0.000356	0.000454	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—PTEN—thyroid cancer	0.000355	0.000452	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—AKT1—thyroid cancer	0.000355	0.000452	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDK1—thyroid cancer	0.000354	0.000451	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—PTEN—thyroid cancer	0.000353	0.000451	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—HRAS—thyroid cancer	0.000353	0.00045	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000352	0.000449	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.000352	0.000448	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000352	0.000448	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—BRAF—thyroid cancer	0.00035	0.000445	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CDK1—thyroid cancer	0.000349	0.000445	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—NRAS—thyroid cancer	0.000348	0.000443	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—NRAS—thyroid cancer	0.000346	0.000441	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—NRAS—thyroid cancer	0.000344	0.000439	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—NRAS—thyroid cancer	0.000343	0.000437	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—thyroid cancer	0.000341	0.000435	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IFNA2—thyroid cancer	0.000341	0.000434	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.00034	0.000433	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TSHR—thyroid cancer	0.000338	0.000431	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IFNA2—thyroid cancer	0.000336	0.000428	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—KRAS—thyroid cancer	0.000335	0.000427	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—HRAS—thyroid cancer	0.000333	0.000425	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—KRAS—thyroid cancer	0.000333	0.000424	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PRKAR1A—thyroid cancer	0.000332	0.000424	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—KRAS—thyroid cancer	0.000329	0.00042	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—TSHR—thyroid cancer	0.000329	0.000419	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CDK1—thyroid cancer	0.000327	0.000417	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—RXRA—thyroid cancer	0.000327	0.000417	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000323	0.000412	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—NRAS—thyroid cancer	0.000322	0.000411	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—NRAS—thyroid cancer	0.000322	0.000411	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	0.000321	0.000409	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—PTEN—thyroid cancer	0.00032	0.000408	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—NRAS—thyroid cancer	0.00032	0.000407	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—KRAS—thyroid cancer	0.000319	0.000406	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MEN1—thyroid cancer	0.000318	0.000405	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—NRAS—thyroid cancer	0.000317	0.000404	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—AKT1—thyroid cancer	0.000316	0.000403	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—NRAS—thyroid cancer	0.000315	0.000402	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—HRAS—thyroid cancer	0.000312	0.000397	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—AKT1—thyroid cancer	0.000312	0.000397	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Metabolism of mRNA—AKT1—thyroid cancer	0.000306	0.00039	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000304	0.000387	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—TPR—thyroid cancer	0.0003	0.000383	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—KRAS—thyroid cancer	0.000299	0.000382	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—TPR—thyroid cancer	0.000299	0.000381	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—KRAS—thyroid cancer	0.000298	0.00038	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—KRAS—thyroid cancer	0.000298	0.00038	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—LGALS3—thyroid cancer	0.000298	0.00038	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—KRAS—thyroid cancer	0.000296	0.000378	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PRKAR1A—thyroid cancer	0.000295	0.000376	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—KRAS—thyroid cancer	0.000295	0.000376	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—AKT1—thyroid cancer	0.000294	0.000375	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PTCH1—thyroid cancer	0.000287	0.000366	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—NRAS—thyroid cancer	0.000286	0.000364	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—HRAS—thyroid cancer	0.000285	0.000363	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000285	0.000363	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NRG1—thyroid cancer	0.000284	0.000362	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—HRAS—thyroid cancer	0.000283	0.000361	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—SST—thyroid cancer	0.000281	0.000359	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MEN1—thyroid cancer	0.000281	0.000358	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NRG1—thyroid cancer	0.00028	0.000357	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—HRAS—thyroid cancer	0.00028	0.000357	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PTCH1—thyroid cancer	0.000279	0.000356	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—KRAS—thyroid cancer	0.000278	0.000354	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—KRAS—thyroid cancer	0.000278	0.000354	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TPR—thyroid cancer	0.000277	0.000353	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000276	0.000352	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—KRAS—thyroid cancer	0.000275	0.000351	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PRKAR1A—thyroid cancer	0.000273	0.000348	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—KRAS—thyroid cancer	0.000273	0.000347	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—KRAS—thyroid cancer	0.000271	0.000346	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CALCA—thyroid cancer	0.000271	0.000345	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—HRAS—thyroid cancer	0.000271	0.000345	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TCF7L1—thyroid cancer	0.000265	0.000338	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TERT—thyroid cancer	0.000264	0.000336	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SST—thyroid cancer	0.000263	0.000335	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NRG1—thyroid cancer	0.000262	0.000335	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Metabolism of RNA—AKT1—thyroid cancer	0.000262	0.000334	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000261	0.000333	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MEN1—thyroid cancer	0.000261	0.000332	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—HRAS—thyroid cancer	0.000256	0.000326	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—SST—thyroid cancer	0.000256	0.000326	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—HRAS—thyroid cancer	0.000254	0.000324	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—HRAS—thyroid cancer	0.000253	0.000323	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—HRAS—thyroid cancer	0.000253	0.000323	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CALCA—thyroid cancer	0.000253	0.000322	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—HRAS—thyroid cancer	0.000252	0.000321	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—HRAS—thyroid cancer	0.000251	0.00032	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—AKT1—thyroid cancer	0.00025	0.000318	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—AKT1—thyroid cancer	0.000247	0.000315	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—PTEN—thyroid cancer	0.000246	0.000314	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CALCA—thyroid cancer	0.000246	0.000314	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—KRAS—thyroid cancer	0.000246	0.000313	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—PTEN—thyroid cancer	0.000244	0.000312	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—NRAS—thyroid cancer	0.000242	0.000309	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—AKT1—thyroid cancer	0.000239	0.000305	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000238	0.000303	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—HRAS—thyroid cancer	0.000236	0.000301	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—HRAS—thyroid cancer	0.000236	0.000301	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TERT—thyroid cancer	0.000236	0.0003	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—HRAS—thyroid cancer	0.000234	0.000298	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TPR—thyroid cancer	0.000232	0.000296	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000232	0.000296	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—HRAS—thyroid cancer	0.000232	0.000295	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—HRAS—thyroid cancer	0.000231	0.000294	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CDK1—thyroid cancer	0.000229	0.000292	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PRKAR1A—thyroid cancer	0.000228	0.000291	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—AKT1—thyroid cancer	0.000226	0.000288	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HIF1A—thyroid cancer	0.000225	0.000287	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—AKT1—thyroid cancer	0.000225	0.000286	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—AKT1—thyroid cancer	0.000224	0.000285	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—AKT1—thyroid cancer	0.000224	0.000285	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CDK1—thyroid cancer	0.000223	0.000284	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—AKT1—thyroid cancer	0.000222	0.000284	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—AKT1—thyroid cancer	0.000221	0.000282	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—NRAS—thyroid cancer	0.00022	0.00028	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—NRAS—thyroid cancer	0.000218	0.000278	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000214	0.000273	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	0.000209	0.000266	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—KRAS—thyroid cancer	0.000209	0.000266	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—AKT1—thyroid cancer	0.000208	0.000265	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—AKT1—thyroid cancer	0.000208	0.000265	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CALCA—thyroid cancer	0.000207	0.000264	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—AKT1—thyroid cancer	0.000206	0.000263	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—PPARG—thyroid cancer	0.000206	0.000263	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—AKT1—thyroid cancer	0.000205	0.000261	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—AKT1—thyroid cancer	0.000204	0.00026	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDK1—thyroid cancer	0.000203	0.000259	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000202	0.000257	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000196	0.00025	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IFNA2—thyroid cancer	0.000196	0.000249	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TSHR—thyroid cancer	0.000194	0.000247	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRKAR1A—thyroid cancer	0.000191	0.000243	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—KRAS—thyroid cancer	0.000189	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CDK1—thyroid cancer	0.000188	0.000239	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—RXRA—thyroid cancer	0.000188	0.000239	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—KRAS—thyroid cancer	0.000188	0.000239	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—BRAF—thyroid cancer	0.000187	0.000238	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—thyroid cancer	0.000185	0.000236	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	0.000184	0.000235	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NRG1—thyroid cancer	0.000184	0.000234	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MEN1—thyroid cancer	0.000182	0.000233	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—HRAS—thyroid cancer	0.000177	0.000226	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of mRNA—AKT1—thyroid cancer	0.000176	0.000224	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000174	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SLC5A5—thyroid cancer	0.000174	0.000221	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CCND1—thyroid cancer	0.000171	0.000217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTCH1—thyroid cancer	0.000165	0.00021	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TERT—thyroid cancer	0.000165	0.00021	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—HRAS—thyroid cancer	0.000164	0.000209	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NRG1—thyroid cancer	0.000163	0.000208	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—HRAS—thyroid cancer	0.000161	0.000205	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—HRAS—thyroid cancer	0.00016	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HIF1A—thyroid cancer	0.000158	0.000201	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—AKT1—thyroid cancer	0.000157	0.000199	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CCND1—thyroid cancer	0.000153	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SST—thyroid cancer	0.000151	0.000192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NRG1—thyroid cancer	0.000151	0.000192	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTGS2—thyroid cancer	0.000151	0.000192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of RNA—AKT1—thyroid cancer	0.00015	0.000192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—RXRA—thyroid cancer	0.000146	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CALCA—thyroid cancer	0.000145	0.000185	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PTEN—thyroid cancer	0.000142	0.000182	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—AKT1—thyroid cancer	0.000142	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—AKT1—thyroid cancer	0.000141	0.00018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PTEN—thyroid cancer	0.00014	0.000179	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NRAS—thyroid cancer	0.000139	0.000177	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—NRAS—thyroid cancer	0.000139	0.000177	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TERT—thyroid cancer	0.000135	0.000173	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CDK1—thyroid cancer	0.000132	0.000168	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTEN—thyroid cancer	0.000131	0.000168	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—BRAF—thyroid cancer	0.000131	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—AKT1—thyroid cancer	0.000131	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HIF1A—thyroid cancer	0.000129	0.000165	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NRAS—thyroid cancer	0.000127	0.000162	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NRAS—thyroid cancer	0.000125	0.00016	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—KRAS—thyroid cancer	0.00012	0.000153	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—KRAS—thyroid cancer	0.00012	0.000153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPARG—thyroid cancer	0.000119	0.000151	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NRAS—thyroid cancer	0.000117	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—KRAS—thyroid cancer	0.000109	0.000139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—KRAS—thyroid cancer	0.000108	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—BRAF—thyroid cancer	0.000107	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—thyroid cancer	0.000106	0.000136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NRG1—thyroid cancer	0.000106	0.000135	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—HRAS—thyroid cancer	0.000102	0.00013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—HRAS—thyroid cancer	0.000102	0.00013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—KRAS—thyroid cancer	0.000101	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—thyroid cancer	0.0001	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AKT1—thyroid cancer	9.89e-05	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCND1—thyroid cancer	9.54e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TERT—thyroid cancer	9.48e-05	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HRAS—thyroid cancer	9.29e-05	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARG—thyroid cancer	9.22e-05	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PTEN—thyroid cancer	9.21e-05	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HRAS—thyroid cancer	9.17e-05	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HIF1A—thyroid cancer	9.07e-05	0.000116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—AKT1—thyroid cancer	8.99e-05	0.000115	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AKT1—thyroid cancer	8.98e-05	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—thyroid cancer	8.66e-05	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HRAS—thyroid cancer	8.58e-05	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NRAS—thyroid cancer	8.21e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AKT1—thyroid cancer	8.21e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PTEN—thyroid cancer	8.18e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—AKT1—thyroid cancer	8.16e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—AKT1—thyroid cancer	8.09e-05	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—NRAS—thyroid cancer	7.99e-05	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—AKT1—thyroid cancer	7.58e-05	9.66e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTEN—thyroid cancer	7.55e-05	9.62e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—BRAF—thyroid cancer	7.51e-05	9.57e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NRAS—thyroid cancer	7.3e-05	9.3e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—thyroid cancer	7.25e-05	9.24e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KRAS—thyroid cancer	7.07e-05	9.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—KRAS—thyroid cancer	6.87e-05	8.76e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NRAS—thyroid cancer	6.74e-05	8.59e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTEN—thyroid cancer	6.32e-05	8.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—thyroid cancer	6.28e-05	8.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KRAS—thyroid cancer	6.28e-05	8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HRAS—thyroid cancer	6.01e-05	7.66e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—HRAS—thyroid cancer	5.84e-05	7.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—KRAS—thyroid cancer	5.8e-05	7.39e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AKT1—thyroid cancer	5.68e-05	7.24e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCND1—thyroid cancer	5.48e-05	6.98e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HRAS—thyroid cancer	5.34e-05	6.8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKT1—thyroid cancer	5.31e-05	6.76e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTEN—thyroid cancer	5.29e-05	6.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AKT1—thyroid cancer	5.16e-05	6.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HRAS—thyroid cancer	4.93e-05	6.28e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NRAS—thyroid cancer	4.72e-05	6.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AKT1—thyroid cancer	4.71e-05	6.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—AKT1—thyroid cancer	4.69e-05	5.97e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKT1—thyroid cancer	4.35e-05	5.55e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KRAS—thyroid cancer	4.06e-05	5.18e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AKT1—thyroid cancer	3.64e-05	4.65e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—thyroid cancer	3.61e-05	4.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HRAS—thyroid cancer	3.45e-05	4.4e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKT1—thyroid cancer	3.05e-05	3.88e-05	CbGpPWpGaD
